About Benjamin Sintay
Form D filings for Fuse Oncology from 2022 to 2023 list Benjamin Sintay as executive officer.
Benjamin Sintay first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Benjamin Sintay in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Benjamin Sintay works with at each company, as listed on that company's latest Form D.
Fuse Oncology, Inc. · Form D, Apr 21, 2023
JM
John Miller
Director
JB
Jay Brennan
Director
JS
John Strider
Executive officer
JB
James Bauler
Chief Executive Officer and director
DW
David Wiant
Executive officer